 |
| |
|
- Zengen Inc.
- Founded in 1999, Zengen, Inc. is a biopharmaceutical company
focused on discovering, developing and commercializing
innovative products to treat and prevent infection and
inflammation through application of its proprietary peptide
technologies. Zengen is currently conducting Phase I/II clinical
trials for CZEN 002, one of the Company’s proprietary peptide
molecules, for the treatment of vulvovaginal candidiasis,
commonly known as vaginal yeast infection.
For more information, please visit
www.zengen.com.
|
 |
|
|
|
